Moringa Capsules Linked to Drug-Resistant Salmonella Outbreak

Federal regulators say the outbreak strain resists all standard first-line and backup antibiotics typically prescribed for salmonella infections.

Federal health regulators are urging consumers not to use certain Rosabella brand moringa capsules after linking the supplements to a multistate salmonella outbreak.

In a safety alert issued February 13, the U.S. Centers for Disease Control and Prevention (CDC) reported at least seven confirmed infections and three hospitalizations tied to now recalled moringa supplements across seven states.

Rosabella moringa capsules are dietary supplements made from moringa oleifera, a plant commonly marketed for its antioxidant and anti-inflammatory properties. The capsules are promoted as supporting energy, metabolism, immune health and overall wellness, though those claims have not been evaluated by the U.S. Food and Drug Administration (FDA).

However, a joint investigation by the CDC and FDA has determined that the reported illnesses following consumption of the dietary supplements involve an extensively drug-resistant strain of Salmonella. 

Drug-Resistant Salmonella Outbreak Details

The CDC reports confirmed cases in Arizona, Florida, Iowa, Illinois, Indiana, Tennessee and Washington. While no deaths have been reported, health officials warn that the strain involved presents significant treatment challenges.

According to federal regulators, the outbreak strain is resistant to all standard first-line and alternative antibiotics typically prescribed for salmonella infections. The bacteria may also resist multiple beta lactam antibiotics, including meropenem and other carbapenems, because it carries an NDM-1 carbapenemase gene.

Due to this resistance profile, infections may not respond to commonly recommended treatments. The CDC advises that antibiotic therapy should be guided by antimicrobial susceptibility testing whenever possible and recommends physicians consult with an infectious disease specialist when managing patients.

Salmonella infections generally cause fever, diarrhea and abdominal cramps within six hours to six days after exposure. Most healthy adults recover within four to seven days without treatment. However, children under 5, adults over 65 and individuals with weakened immune systems face a higher risk of severe illness, dehydration or hospitalization.

Rosabella Moringa Recall

As a result of the investigation findings, Ambrosia Brands LLC has issued a voluntary recall for certain lots of Rosabella moringa capsules.

The affected products are sold in white plastic bottles with green labels. The company has identified 52 impacted lots, with lot codes printed on the bottom of the bottle alongside expiration dates extending into 2027. The FDA has published a complete list of affected lot numbers.

The capsules were sold nationwide through tryrosabella.com, as well as through Amazon, TikTok Shop, Shein and eBay.

Health officials urge consumers not to take the recalled capsules. Individuals who purchased the product should discard it immediately or return it for a refund, wash any surfaces the capsules may have contacted, and monitor for symptoms such as high fever, dehydration, bloody diarrhea or vomiting. Anyone experiencing symptoms after using the product should contact a healthcare provider.

Sign up for more safety and legal news that could affect you or your family.